Created by co-founders of the $40B DNA sequencing leader Illumina, Luna DNA incentivizes the sharing of DNA and medical information for research. Luna rewards people for sharing the data they already own while contributing to medical research and discovery that saves lives. DNA sequencing data has become siloed. As personal DNA sequencing has risen in popularity, the data has become siloed as each company looks to maximize their individual profit from this data. There is currently little incentive for consumers to contribute their DNA and health information to a third party database. There are also multiple privacy, security, and trust issues that limit broad participation. The solution is Luna DNA. Luna is a community owned database that rewards individuals shares in the database and rewards for contributing their DNA and other medical information. Shares entitle members to a share in the profits from medical research and discoveries. The proceeds flow back to the community like dividends as researchers pay to access the data for discovery.

Created by co-founders of the $40B DNA sequencing leader Illumina, Luna DNA incentivizes the sharing of DNA and medical information for research. Luna rewards people for sharing the data they already own while contributing to medical research and discovery that saves lives. DNA sequencing data has become siloed. As personal DNA sequencing has risen in popularity, the data has become siloed as each company looks to maximize their individual profit from this data. There is currently little incentive for consumers to contribute their DNA and health information to a third party database. There are also multiple privacy, security, and trust issues that limit broad participation. The solution is Luna DNA. Luna is a community owned database that rewards individuals shares in the database and rewards for contributing their DNA and other medical information. Shares entitle members to a share in the profits from medical research and discoveries. The proceeds flow back to the community like dividends as researchers pay to access the data for discovery.

Veracyte develops innovative molecular diagnostic tests that provide clinicians with critical insights to enhance cancer diagnosis and treatment, ultimately aiming to improve patient outcomes and reduce healthcare costs.

Veracyte develops innovative molecular diagnostic tests that provide clinicians with critical insights to enhance cancer diagnosis and treatment, ultimately aiming to improve patient outcomes and reduce healthcare costs.